Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04334057
Recruitment Status : Enrolling by invitation
First Posted : April 3, 2020
Last Update Posted : October 5, 2021
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : February 28, 2025
Estimated Study Completion Date : February 28, 2025